Evaluation of new non-invasive technologies for detecting COVID-19 and other respiratory infections
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
This study is testing new non-invasive devices to see if they can accurately detect COVID-19 and other respiratory infections in adults, compared to standard testing methods.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | The Geneva Foundation Academic / other |
| Locations | 1 site (Fort Sam Houston, Texas) |
| Trial ID | NCT05765396 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the effectiveness of the imPulse™ Una and TOR e-stethoscopes in detecting COVID-19, Flu, and RSV in both symptomatic and asymptomatic individuals aged 18 and older. Participants will undergo standard screening and testing at Brooke Army Medical Center in Fort Sam Houston, Texas. The study will compare the detection capabilities of these devices against the gold standard RT-PCR tests. The goal is to improve rapid and reliable diagnostics for respiratory infections, particularly in military settings where such infections can significantly impact operational readiness.
Who should consider this trial
Good fit: Ideal candidates for this study are asymptomatic and symptomatic individuals aged 18 and older who are undergoing COVID-19, Flu, and/or RSV screening at BAMC.
Not a fit: Patients under the age of 18 or those unable to comply with study procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more efficient and non-invasive methods for diagnosing respiratory infections, enhancing patient care and military readiness.
How similar studies have performed: While the approach of using non-invasive detection technologies is innovative, similar studies have shown promise in improving diagnostic capabilities for respiratory infections.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Asymptomatic and symptomatic individuals 18 years and older * Receiving standard COVID-19, Flu, and/or RSV screening and testing at BAMC * Do not have to be diagnosed with SARS-CoV-19 (COVID-19), Flu, and/or RSV but only be screened * English Speaking Exclusion Criteria: * Any individual under age of 18 * Anyone unable to comply (or be assisted) with study procedures * Anyone not able to provide temperature thermal scan, and/or 3-minute vibroacoustic scan
Where this trial is running
Fort Sam Houston, Texas
- Brooke Army Medical Center — Fort Sam Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Tony T Yuan, PhD — Uniformed Services University of the Health Sciences (USUHS)
- Study coordinator: Tony T Yuan, PhD
- Email: tony.yuan@usuhs.edu
- Phone: 214-292-0508
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.